Clinical trial
Prospective Clinicogenomic Program
NCT04180176
Study timeline
Study start (actual)2019-12-13Date precision: day
Registry last updated2024-01-17
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non-Small Cell Lung Cancer (NSCLC)unresolved
Small-Cell Lung Cancer (SCLC)unresolved
Interventions
Blood DrawOTHER
Sponsors & collaborators
Genentech, Inc.lead sponsor
Flatiron Health, Inc.; Foundation Medicine, Inc.collaborator
Mapped research locations
New YorkNew York, United States1AtlantaGeorgia, United States1NashvilleTennessee, United States1BirminghamAlabama, United States1New HavenConnecticut, United States1RichmondVirginia, United States1TulsaOklahoma, United States1West Palm BeachFlorida, United States1Grand RapidsMichigan, United States1St. PetersburgFlorida, United States1LincolnNebraska, United States1Fort MyersFlorida, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT04180176 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.